Skip to main content
. 2017 Mar 8;9(4):508–530. doi: 10.15252/emmm.201506111

Figure EV2. The effect of the PPARG antagonist GW9662 on the growth of UMB and AK cells.

Figure EV2

Relative growth ratios of primary human adult kidney cells (AK) and UMB cells treated with varying concentrations of GW9662 for 48 h. Vehicle‐treated cells served as control. Results shown as mean ± SD (n = 3). *P < 0.05 (one‐way ANOVA with Bonferroni post hoc test). The exact P‐values are specified in Appendix Table S5.